NCT02273518View on ClinicalTrials.gov

Study to Compare the Pharmacokinetics of Dipyridamole in Three Different Asasantin Extended Release (ER) Formulations in Healthy Male and Female Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

April 30, 2001

Primary Completion Date

May 31, 2001

Conditions
Healthy
Interventions
DRUG

Asasantin ER, new formulation I

DRUG

Asasantin ER, new formulation II

DRUG

Asasantin ER, present commercial formulation

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02273518 - Study to Compare the Pharmacokinetics of Dipyridamole in Three Different Asasantin Extended Release (ER) Formulations in Healthy Male and Female Volunteers | Biotech Hunter | Biotech Hunter